A commercial monovalent canine parvovirus vaccine performs better than a commercial combination vaccine in puppies


Published: Jan 21, 2023
Keywords:
Dogs Primodog Duramune enteritis and serum antibody
MU Asghar
AA Anjum
M Rabbani
MA Khan
MA Ali
S Azeem
https://orcid.org/0000-0002-1261-2034
Abstract

Thirty puppies were randomly divided in to 3 groups for comparative evaluation of two commercial CPV vaccines. Each group was further subdivided in to < 6 months and < 3 months -old puppies and either vaccinated with a monovalent vaccine: Primodog, a combination vaccine: Duramune or maintained as a non-vaccinated control. Humoral immune response was determined by Hemagglutination Inhibition (HAI) on 21 and 35 -days after vaccination. The geometric mean titer (GMT) induced by Duramune, 21 and 35 -days post-vaccination was GMT 73.3 and 137.2, respectively. Comparatively, Primodog demonstrated higher GMT on 21 and 35 -days after vaccination: 97.0 and 168.9, respectively. The older puppies (< 6 months old) demonstrated higher seroconversion to both vaccines.

Article Details
  • Section
  • Research Articles
Downloads
Download data is not yet available.
Author Biography
S Azeem, University of Veterinary and Animal Sciences, Lahore, Pakistan

Assistant Professor, Institute of Microbiology

References
Anderson N, Smith I (2019) Assessing the immunogenicity of an inactivated monovalent vaccine in the endangered African wild dog (Lycaon pictus). Vaccine X 1:100006. https://doi.org/10.1016/j.jvacx.2019.100006
Crow SE, Walshaw SO, Boyle JE (2009) Blood collection. In: Manual of clinical procedures in dogs, cats, rabbits and rodents. 3rd ed. Wiley-Blackwell, Singapore: pp 19-34.
Gueorguieva R, Krystal JH (2004) Move over ANOVA: Progress in Analyzing Repeated-Measures Data and Its Reflection in Papers Published in the Archives of General Psychiatry. Arch Gen Psychiatry. 61:310–307.
Miyaji K, Suzuki A, Shimakura H, Takase Y, Kiuchi A, Fujimura M Kurita G, Tsujimoto H, Sakaguchi M 2012 Large-scale survey of adverse reactions to canine non-rabies combined vaccines in Japan. Vet Immunol Immunopathol 145:447–452. http://dx.doi.org/10.1016/j.vetimm.2011.12.023.
Mochizuki M, Hashimoto M, Hajima T, Takiguchi M, Hashimoto A, Une Y, Roerink F, Ohshima T, Parrish CR, Carmichael LE. (2002) Virologic and serologic identification of minute virus of canines (canine parvovirus type 1) from dogs in Japan. J Clin Microbiol 40:3993–3998.
Nandi S, Kumar M (2010) Canine parvovirus: Current perspective. Indian J Virol 21:31–44.
Nauta J (2011) Statistics in clinical vaccine trials. Netherlands: Springer-Verlag, Germany: pp. 20-21.
Palmer DF, Dowdle WR, Coleman MT, Schild GC (1975) Advanced laboratory techniques for influenza diagnosis. Washington: U.S. Dept. of Health, Education, and Welfare, Public Health Service. pp. 26-45.
Pratelli A, Cavalli A, Martella V, Tempesta M, Decaro N, Carmichael LE, Buonavoglia C. (2001) Canine parvovirus (CPV) vaccination: Comparison of neutralizing antibody responses in pups after inoculation with CPV2 or CPV2b modified live virus vaccine. Clin Diagn Lab Immunol 8:612–615.
Razmaraii N, Toroghi R, Babaei H, Khalili I, Sadigh-Eteghad S, Forghy L (2012) Immunogenicity of commercial, formaldehyde and binary ethylenimine inactivated Newcastle disease virus vaccines in specific pathogen free chickens. Razi Arch Razi Inst 67:21–25.
Shabbir MZ, Sohail MU, Chaudhary UN, Yaqub W, Rashid I, Saleem MH, Munir M (2017) Genetic Characterization of a canine parvovirus from dogs in Pakistan. Acta Virol 61:175–182.
Spickler AR, Roth JA (2003) Adjuvants in Veterinary Vaccines: Modes of Action and Adverse Effects. J Vet Intern Med 17:273–281.
Willem C, Lacheretz A, Latour S (2001) Control of canine parvovirus infection in breeding kennels : Study of the efficacy of a high titer attenuated canine parvovirus vaccine. Rev Med Vet (Toulouse). 152:373–378.
Most read articles by the same author(s)